Respiratory Drugs Market: Current Analysis and Forecast (2021-2027)

Respiratory Drugs Market: Current Analysis and Forecast (2021-2027)

The global respiratory drug Market is anticipated to grow with a CAGR of around 5% over the forecast period (2021-2027). The overall incidence of respiratory diseases has increased in recent decades due to rising pollution and industrialization. For instance, according to the Global Initiative for Chronic Obstructive Lung Disease, in 2019, globally around 384 million people suffer from COPD and ~3 million people die each year. Therefore, to reduce the number of cases or to provide the proper cure, the demand for respiratory drugs is increasing. Moreover, increasing the government’s focus on improving healthcare infrastructure to provide proper treatment to the patient is expected to boost the market for respiratory drugs. For instance, India’s National Health Policy (2017) aims to increase Government spending on health to 2.5% of GDP by 2025.

Abbott Laboratories, AbbVie Inc., Aerogen Pharma Ltd., AstraZeneca Plc, Aurobindo Pharma Ltd., Boehringer Ingelheim International GmbH, Celon Pharma S.A., Cipla Ltd., F. Hoffmann La Roche Ltd., and GlaxoSmithKline Plc, are some of the prominent players operating in the respiratory drug market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with new and advanced drugs.

Insights Presented in the Report
"Amongst drug class, short-acting beta2-agonists (SABA) segment holds the major share”

Based on drug class, the market has been distributed into, short-acting beta2-agonists (SABA), long-acting beta 2-agonists (LABA), inhaled corticosteroids (ICS), anticholinergics, antihistamines, vasodilators, and combination drugs. Among these, SABA is known as a quick-acting and reliving drug from unforeseen asthma attacks, as it helps to rapidly open the airways. As, a large number of respiratory disease patients are suffering from asthma problems, therefore the demand for this drug class is high. Further, new technological advancements and product innovations are propelling its market demand. For instance, conventionally SABA is used as an injectable but with the advancement in technology, now it is also used in inhalers.
"Amongst disease types, chronic obstructive pulmonary disease (COPD) segment holds the major share”

Based on disease type, the market is categorized into asthma, chronic bronchitis, COPD, and pleural effusion. According to Global Initiative for Chronic Lung Disease, 384 million people suffer from COPD, and 3 million die from it each year, making it the third leading cause of death worldwide. As a result, the demand for drugs to treat the patients is considerably high for COPD. Further, environmental exposure to tobacco smoke, air pollution, occupational dust, fumes, and chemicals are important risk factors for COPD. This is likely to increase the cases of COPD in the foreseeable future, thereby boosting the market.
"North America represents one of the largest markets in respiratory drug market”

For a better understanding of the market dynamics of the respiratory drug market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, the United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, and Rest of APAC) and Rest of World has been conducted. North America constitutes a major market for the respiratory drug market industry in 2020 owing to the presence of well-established market players in the region and frequent drug launches.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts
• The report presents a quick review of overall industry performance at one glance
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
• The study comprehensively covers the market across different segments
• Deep dive regional level analysis of the industry